Viruses and Atherosclerosis: Do They Play a Pathogenic Role?

Journal of Investigative Medicine

Volumn 46, Issue 8, 1998, Pages 403-407

  Vercellotti, Gregory M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTERIOSCLEROSIS; HUMAN; REVIEW; VIROLOGY; VIRUS INFECTION;

ANIMALS; ARTERIOSCLEROSIS; HUMANS; VIRUS DISEASES;

EID: 0032185150     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Osler W, editor. Modern medicine. Its theory and practice. Vol. IV, Philadelphia and New York: Lea & Lebiger, 1908: 427-46.
2. Saikku P. Chlamydia pneumoniae and atherosclerosis - an update. Scand J Infect Dis 1997;104(Suppl):53-6.
3. Mattila KJ, Valtonen VV, Nieminen MS. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;26:719-34.
4. Gupta S, Camm AJ. Chronic infection in the etiology of atherosclerosis - the case for Chlamydia pneumoniae. Clin Cardiol 1997;20:829-36.
5. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1217-25.
6. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
7. Phinney P, Fligiel S, Bryson Y, Porter D. Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection. Arch Pathol Lab Med 1982;106:64-7.
8. Paterson JC, Cottral GE. Experimental coronary sclerosis. III: lymphomatosis as a cause of coronary sclerosis in chickens. Arch Pathol 1950;49:669-707.
9. Fabricant CG, Fabricant J, Litrenta M, Minick C. Virus induced atherosclerosis. J Exp Med 1978;148:335-40.
10. Minick CR, Fabricant CG, Fabricant J, Litrenta MM. Atheroarteriosclerosis induced by infection by herpesvirus. Am J Pathol 1978;96:673-706.
11. Peersoons MCJ, Daemen MJAP, Bruning JH, Bruggeman CA. Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats: a clue to herpes virus-associated atherogenesis. Circ Res 1994;75:214-20.
12. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973;70:1753-6.
13. Benditt E, Barrett T, McDougall J. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983;80:6386-9.
14. Melnick J, Dreesman G, McCollum C, Petrie B, Burek J, DeBakey M. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983;2:644-6.
15. Yamashiroya H, Ghosh L, Yang R, Robertson A. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988;130:71-9.
16. Gyorkey F, Melnick J, Guinn G, Gyorkey P, DeBakey M. Herpes viridae in endothelial cells of the proximal aorta of atherosclerotic patients. Exp Mol Pathol 1984;40:328-39.
17. Hendrix M, Salimans M, van Boven C, Bruggeman C. High prevalence of latently present cytomegalovirus in artery walls of patients suffering grade III atherosclerosis. Am J Pathol 1990;136:23-8.
18. Adam E, Melnick J, Probesfield J, Petrie B, Burek J, Bailey K, McColum C, DeBakey M. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;2:291-3.
19. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick SL (for the ARIC Study Investigators). Cytomegalovirus/herpesvirus and carotid atherosclerosis: The ARIC Study. J Med Virol 1994;42:33-7.
20. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 197;96:2144-8.
21. Nieto FJ, Sorlie P, Comstock GW, Wu K, Adam E, Melnick JL, Szklo M. Cytomegalovirus infection, lipoprotein (a), and hypercoagulability: an atherogenic link? Arterioscl, Thromb Vasc Biol 1997;17(9):1780-5.
22. Havlik R, Blackwelder W, Kaslow R, Castelli W. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages: the Framingham Heart Study. Arteriosclerosis 1989;9:877-80.
23. Kol A, Sperti G, Shani J, Schulhoff N, van de Greef W, Landini MP, La Placa M, Maseri A, Crea F. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 1995;91:1910-3.
24. Grattan M, Moreno-Cabral C, Starnes V, Oyer P, Stinson E, Shumway N. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-6.
25. McDonald K, Rector T, Braunlan E, Coubo S, Olivari M. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Pathol 1989;64:359-62.
26. Gulizia J, Kandolf R, Kendall T, Thieszen S, Wilson J, Radio S, Costanzo M, Winters G, Miller L, McManus B. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 1995;147:461-75.
27. Skowronski E, Mendoza A, Smith S, Jaski B. Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction: implications of cytomegalovirus association with graft atherosclerosis. J Heart Lung Transplant 1993;12:717-23.
28. Hosenpud J, Chou S, Wagner W. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 1991;52:896-903.
29. Ustinov J, Koginov R, Bruggeman C, van der Meide P, Hayry P, Lautenschlager I. Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart Lung Transplant 1993; 12:644-51.
30. Sedmak DD, Guglielmo AM, Knight DA, Birmingham DJ, Huang EH, Waldman WJ. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 1994; 144:683-92.
31. Bruggeman CA, van Dam-Mieras MCE. The possible role of cytomegalovirus in atherogenesis. In: Melnick JL, ed. Prog Med Virol. Basel:Karger, 1991;38:1-26.
32. Sedmak DD, Knight DA, Vook NC, Waldman WJ. Divergent patterns of ELAM-1, ICAM-1 and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994;58:1379-85.
33. Lemstrom K, Aho P, Bruggeman C, Hayry P. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Arterioscler Thromb 1994;14:2043-52.
34. Speir E, Shibutani T, Yu Z, Ferrans V, Epstein S. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 1996;79:1143-52.
35. Vossen RCRM, van Dam-Mieras MCE, Bruggeman CA. Cytomegalovirus infection and vessel wall pathology. Intervirology 1996;39:213-21.
36. Yurochko AD, Kowalik TF, Huong SM, Huang ES. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 1995;69(9):5391-400.
37. Zhou Y, Leon M, Maclawiw M, Popma J, Yu Z, Finkel T, Epstein S. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.
38. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 1998;81:866-8.
39. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton S. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation 1992; 86(Suppl III):III-47-III-52.
40. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331:417-24.
41. Speir E, Modali R, Huang E, Leon M, Shawl F, Finkel T, Epstein S. Potential role of human cytomegalovirus and p53 interaction in coronary atherosclerosis. Science 1994;265:391-4.
42. Zhu H, Shen Y, Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 1995;69:7960-70.
43. Kovacs A, Weber M, Burns L, Jacob H, Vercellotti G. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am J Pathol 1997;149:1531-9.
44. Baas I, Offenhaus J, El-Deiry W, Wu T, et al. The WAF-1mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipients. Hum Pathol 1997;27:324-9.
45. Moldow CF, Vercellotti GM. Herpesvirus effects on proinflammatory and procoagulant properties of endothelial cells. In: Hajjar D, Schwartz S eds. The role of vascular viral infections in atherosclerosis. Chur, Switzerland: Harwood Academic Publishers. In press.
46. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. BioEssays 1995;17:899-903.
47. Nicholson AC, Hajjar DP. Herpesvirus in atherosclerosis and thrombosis. Etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 1998;18:339-48.
48. Vercellotti GM. Potential role of viruses in thrombosis and atherosclerosis. Trends Cardiovasc Med 1995;5:128-33.
49. Visser M, Vercellotti G. Herpes simplex virus and atherosclerosis. Eur Heart J 1993;14(Suppl K):39-42.
50. Hajjar D. Viral pathogenesis of atherosclerosis: impact of molecular mimicry and viral genes. Am J Pathol 1991;139:1195-1211.
51. Macgregor RR, Friedman HM, Macarak EJ, Kefalides NA. Virus infection of endothelial cells increases granulocyte adherence. J Clin Invest 1980;65:1469-77.
52. Visser M, Jacob H, Goodman J, McCarthy J, Furcht L, Vercellotti G. Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab Invest 1989;60:296-304.
53. Span A, van Boven C, Bruggeman C. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest 1989; 19:542-8.
54. Cines DB, Lyss AP, Bina M, Corkey R, Kefalides NA. Fc and C3 receptors induced by Herpes simplex virus infection in cultured endothelial cells. J Clin Invest 1982;69:123-8.
55. Etingin O, Silverstein R, Hajjar D. Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc Natl Acad Sci USA 1991;88:7200-3.
56. van Dam-Mieras M, Muller A, van Hinsbergh V, Mullers W, Bomans P, Bruggeman C. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992;68:364-70.
57. Visser M, Tracy P, Vercellotti G, Goodman J, White J, Jacob H. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci USA 1988;85:8227-30.
58. Pryzdial E, Wright J. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 1994;84:3749-57.
59. Etingin O, Silverstein R, Friedman H, Hajjar D. Viral activation of the coagulation cascade: molecular interactions at the surface of the infected endothelial cell. Cell 1990;61:657-62.
60. Altieri D, Etingin O, Fair D, Brunck T, Geltosky J, Hajjar D, Edgington T. Structural homologous ligand binding of integrin mac-1 and viral glycoprotein C receptors. Science 1991; 254:1200-3.
61. Key N, Bach R, Vercellotti G, Moldow C. Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. Lab Invest 1993;68:645-51.
62. Kaner R, Iozzo R, Ziaie Z, Kefalides N. Inhibition of proteoglycan synthesis in human endothelial cells after infection with herpes simplex virus type 1 in vitro. Am J Respir Cell Mol Biol 1990;2:423-31.
63. Key N, Vercellotti G, Winkelmann J, Moldow C, Goodman J, Esmon N, Esmon C, Jacob H. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 1990;87:7095-7.
64. Bok RA, Jacob HS, Balla J, Juckett M, Stilla T, Shatos MA, Vercellotti GM. Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor. Thromb Haemost 1993;69(3):253-8.
65. Etingin O, Silverstein R, Hajjar D. von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA 1993;90:5153-6.
66. Hajjar D, Falcone D, Fabricant C, Fabricant J. Altered cholesteryl ester cycle is associated with lipid accumulation in herpesvirus-infected arterial smooth muscle cells. J Biol Chem 1985;260:6124-8.
67. Hajjar D. Herpesvirus infection prevents activation of cytoplasmic cholesteryl esterase in arterial smooth muscle cells. J Biol Chem 1986;261:7611-4.
68. Hajjar D, Nicholson A, Hajjar K, Sando G, Summers B. Decreased messenger RNA translation in herpesvirus-infected arterial cells: effects on cholesteryl ester hydrolase. Proc Natl Acad Sci USA 1989;86:3366-70.
69. Zhou Y, Guetta E, Yu Z, Finkel T, Epstein S. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 1996;98:2129-38.
70. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
71. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 1996;212:1061-5.